PRA Agrees to Buyout

Genstar Capital has agreed to acquire clinical research organization PRA International (Nasdaq: PRAI) for approximately $790 million. PRA stockholders would receive $30.50 per share in cash, which is a 13% premium to yesterday's closing price. Credit Suisse is advising PRA, while UBS is advising Genstar. www.gencap.com www.prainternational.com